Cabaletta Bio Inc.
CABA | NASDAQ
$2.46
-$0.09 (-3.53%)
At close: Sep 21, 2026, 4:00 PM ET
$2.46
$0 (0.00%)
Pre-market:
Sep 22, 2026, 6:25 AM ET
Market Data
Market Cap $401.11M
Enterprise Value $201.73M
Beta 3.26
Average Volume 4.82M
Shares Outstanding (Diluted) 151.16M
Shares Change YoY 144.29%
Institutional Ownership 75.59%
Exchange NASDAQ
ISIN US12674W1099
Price Performance
Price Change 1M -20.4%
Price Change 3M -18.5%
Price Change 6M -11.5%
Price Change YTD 11.3%
Price Change 1Y 6.5%
Price Change 3Y -84.5%
Price Change 5Y -79.5%
1M CAGR (ann.) -11.8%
1Y CAGR (ann.) 12.8%
5Y CAGR (ann.) -26.6%
All-Time CAGR -18.4%
Valuation
PE Ratio -1.56
Forward PE N/A
PEG Ratio -0.03
Forward PEG 0.13
PS Ratio N/A
Forward PS 562.90
PB Ratio 1.90
P/FCF Ratio -2.60
P/Adj. FCF Ratio -2.29
P/OCF Ratio -2.41
EV/Sales N/A
EV/EBIT -1.13
EV/EBITDA -1.14
EV/FCF -1.31
Earnings Yield -64.2%
FCF Yield -38.5%
Adj. FCF Yield -43.6%
Financial Health
Net Cash $225.1M
Total Debt $25.71M
Cash & Short-Term Investments $225.1M
Total Assets $256.73M
Current Ratio 5.79
Quick Ratio 5.79
Debt / Equity Ratio 0.12
Debt / EBITDA -0.15
Debt / FCF -0.17
OCF / Debt -5.99
Interest Coverage -80.94
Altman Z-Score 0.47
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -13.5%
Returns
Return on Assets -70.6%
Return on Equity -128.3%
Return on Invested Capital -78.5%
Return on Capital Employed -85.6%
Return on Tangible Assets -70.6%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 8.0%
EPS CAGR 5Y -2.8%
EPS CAGR 10Y N/A
FCF CAGR 3Y -35.0%
FCF CAGR 5Y -32.2%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 12
EPS Growth Next 3Y 23.4%
Revenue Growth Next 3Y N/A
Earnings Date Nov 8, 2026
EPS Estimate (next Q) -$0.33
EPS Growth Est (next Q) -25.0%
Revenue Est (next Q) $1.67M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $16.33
Price Target Upside 563.8%
Cash Flow
Operating Cash Flow $-153.93M
Free Cash Flow $-154.21M
Adj. Free Cash Flow $-175.04M
FCF Per Share -$1.02
OCF Per Share -$1.02
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-185.52M
EBITDA $-176.92M
Net Income $-181.32M
EPS (Diluted) -$1.58
Revenue / Employee N/A
Profit / Employee $-1.16M
Employees 156
Add to Watchlist
Select watchlists to add or remove CABA